In a bid to expand its manufacturing plant in Scotland, Piramal Healthcare has invested two million pounds. The company is aiming to expand this facility in the next 5 years to maintain its position as a global leader in the production of antibody drug conjugates.
The plant manufactures anti-cancer drugs (antibody drug conjugates) for export. The investment of two million pounds into Scotland will yield additional revenue of 3-5 million pounds over five years to Piramal Healthcare’s revenue.
Piramal Enterprises is one of India’s large diversified companies, with a presence in Healthcare, Healthcare Information Management and Financial Services. Its consolidated revenues were over $830 million in FY2015, with approx. 70% of revenues from outside India.
| Company Name | CMP |
|---|---|
| Bajaj Finance | 908.70 |
| Shriram Finance | 1036.50 |
| Aditya Birla Capital | 340.20 |
| Chola Invest & Fin. | 1579.65 |
| Tata Capital | 337.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: